I had to laugh recently. Various advertising from diabetes companies comes through my feeds, and this time it was an ad from Medtronic Australia, touting the improvements in TIR (Time In Range) for their 670G pump. Here it is reproduced in its entirety: I’m not sure exactly where they sourced this data, but presumably …
Since my last post about rumours of legal action regarding CGM pricing in Australia, I’ve learnt more about the way the NDSS supply system works. As it turns out it’s just refinements of the “lay view” I outlined previously. This applies for all NDSS supplies, including CGM. If you don’t know what all the fuss is …
There has been a lot of excitement in Australia about the discovery of a cheaper way of accessing the Dexcom G5 CGM. Read that article if you haven’t already. Many people have discovered that yes they can afford to use this life-changing technology. Incidentally, the Medtronic CGM transmitters and sensors have also been available via …
At last week’s diabetes congress in Sydney, Accu-Chek announced that the tubeless Solo pump will be available in November once the government’s Prostheses List is next updated. The Prostheses List controls which pumps are available through private health insurance, and is only updated several times a year. I mentioned this in the ADC 2019 – Day …
WARNING (February 2021): The situation has changed again. Pharmacy prices for CGM are now sky-high. At the 2019 Australasian Diabetes Congress (last week) no announcements were made about Dexcom G6. It’s still waiting for approval from the TGA before AMSL will be able to start selling or even marketing it. The strongest story I heard …
Day 2 of the Australasian Diabetes Congress didn’t have many new technology announcements, but it did involve lots more presentations. Many more than I was able to attend. I’ve already reported on the Ypsomed announcement of new infusion set options. The other highlights for me included: A masterclass on some of the issues with including …